Aimmune Therapeutics, Inc. Net Income 2015-2020 | AIMT
Aimmune Therapeutics, Inc. net income from 2015 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Aimmune Therapeutics, Inc. Annual Net Income (Millions of US $) |
|
|---|---|
| 2019 | $-248 |
| 2018 | $-211 |
| 2017 | $-131 |
| 2016 | $-81 |
| 2015 | $-36 |
| 2014 | $-11 |
| 2013 | $-5 |
| Aimmune Therapeutics, Inc. Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2020-06-30 | $-69 |
| 2020-03-31 | $-86 |
| 2019-12-31 | $-67 |
| 2019-09-30 | $-64 |
| 2019-06-30 | $-63 |
| 2019-03-31 | $-54 |
| 2018-12-31 | $-57 |
| 2018-09-30 | $-52 |
| 2018-06-30 | $-53 |
| 2018-03-31 | $-50 |
| 2017-12-31 | $-41 |
| 2017-09-30 | $-32 |
| 2017-06-30 | $-32 |
| 2017-03-31 | $-26 |
| 2016-12-31 | $-25 |
| 2016-09-30 | $-22 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-16 |
| 2015-12-31 | $-16 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-7 |
| 2015-03-31 | $-3 |
| 2014-09-30 | $-3 |
| 2014-06-30 | $-3 |
